Back to STATE STREET CORP STATE STREET CORP

XENEXENE
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in XENON PHARMACEUTICALS INC

STATE STREET CORP holds 2M shares of XENE (XENON PHARMACEUTICALS INC), worth $118.9M as of 2026-Q2. The position was increased (+14.5% shares). XENE represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$118.9M

Current Shares

2M

Total Value Change

+$108.4M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+14.5%
$118.9M0.0%$60.36
34
2026-Q1
Increased
1.7M
+15.3%
$100M0.0%$43.79
34
2025-Q4
Increased
1.5M
+1.8%
$66.9M0.0%$44.12
30
2025-Q3
Increased
1.5M
+6.2%
$58.9M0.0%$39.06
31
2025-Q2
Increased
1.4M
+351.7%
$43.2M0.0%$32.40
47
2025-Q1
Increased
305,620
+5.8%
$10.3M0.0%$34.26
29
2024-Q4
Increased
288,722
+3.3%
$11.3M0.0%$38.53
29
2024-Q3
Increased
279,513
+13.3%
$11M0.0%$38.65
31
2024-Q2
Increased
246,812
+1.7%
$9.6M0.0%$38.99
28
2024-Q1
Increased
242,640
+6.9%
$10.4M0.0%$43.05
30
2023-Q4
New
227,040
-
$10.5M0.0%$46.06
38

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used